Cisco
CSCO
NVIDIA
NVDA
Broadcom
AVGO
4
Taiwan Semiconductor
TSM
5
ASML Holding
ASML
US Stock MarketDetailed Quotes
FHTX Foghorn Therapeutics
- 3.520
- -0.360-9.28%
Close Mar 28 16:00 ET
- 3.690
- +0.170+4.83%
Post 17:39 ET
195.76MMarket Cap-2.23P/E (TTM)
3.870High3.515Low78.49KVolume3.870Open3.880Pre Close286.12KTurnover0.30%Turnover RatioLossP/E (Static)55.61MShares10.25052wk High-4.30P/B90.98MFloat Cap3.51552wk Low--Dividend TTM25.85MShs Float28.265Historical High--Div YieldTTM9.15%Amplitude2.700Historical Low3.645Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Foghorn Therapeutics Stock Forum
Breakthrough Cancer Drug FHD-909 Reveals Powerful Combination Potential Against Lung Cancer
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If yo...
Flagship Pioneering Unveils Lila Sciences to Build Superintelligence in Science
Monday, 10th March at 11:29 am
AI platform combined with autonomous labs will accelerate discovery across every domain of science
Company has raised $200M in seed financing to further develop platform and build first AI Science Factories
CAMBRIDGE, Mass., March 10, 2025 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today unveiled Lila Sciences, a company ...
Foghorn Therapeutics Inc. - Phase 1 Trial of Fhd-286 Showed Clinical Responses but Did Not Meet Threshold
Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities
Monday, 16th December at 7:00 am
Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine in patients with relapsed and/or refractory AML; efficacy threshold not achieved to support continued development by Foghorn alone
Company to prioritize investment into proprietary pipe...
NEWS
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
NEWS
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
Foghorn Therapeutics Inc. (Nasdaq: FHTX) announced plans to host a conference call and webcast on April 9th to review key pipeline programs, including FHD-286 for AML and new preclinical data for FHD-909 and selective CBP and EP300 degrader programs.
No comment yet